Open AccessSuccessful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction
Author(s) -
Nakahara Ryosuke,
Sumimoto Takahiro,
Tanaka Ryota,
Ogata Masao,
Itoh Hiroki
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4357
Subject(s) - medicine , imatinib , myeloid leukemia , dosing , dialysis , therapeutic drug monitoring , drug , intensive care medicine , imatinib mesylate , regimen , pharmacology
Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.